JohnColeMD

PubMed

• 1 citations
  Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience.
  Julia Levy, Fady Farag, John Cole> ;Breast Cancer Research and Treatment. 2022 Nov 1
• 52 citations
  Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
  Michael Lunski, Jeffrey H. Burton, Karine Tawagi, Diana Maslov, Victoria Simenson, Daniel Barr, Helen Yuan, Daniel H. Johnson, Marc R. Matrana, John T. Cole, Zoe L Lar...> ;Cancer. 2021 Jan 15
• A Diagnostic Approach to Stroke in Young Adults.
  Stack, C. A.,Cole, J. W.> ;Curr Treat Options Cardiovasc Med. 2017 Sep 28
• 53 citations
  Endocrine Therapy for Early Breast Cancer: Updated Review.
  Alexander Tremont, Jonathan J. Lu, John T. Cole> ;Ochsner Journal. 2017 Jan 1
• 1 citations
  Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy.
  Eiman Jahangir, Sangeeta Shah, Kelly Shum, Caitlin Baxter, Jill D Fitzpatrick, John T. Cole, Yvonne Gilliland, Nichole M. Polin> ;Southern Medical Journal. 2015 Feb 1
• Recommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collection.
  Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YY, Gurol ME, Lindgren AG, Woo D, Fernandez-Cadenas I, Chen DT, Thijs V, Worrall BB, Kamal A, Bentley P, Wardlaw JM, Ru...> ;Stroke. 2015-01-01
• Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network.
  Ay H, Arsava EM, Andsberg G, Benner T, Brown RD, Chapman SN, Cole JW, Delavaran H, Dichgans M, Engström G, Giralt-Steinhauer E, Grewal RP, Gwinn K, Jern C, Jimenez-Con...> ;Stroke. 2014-12-01
• Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.
  McArdle PF, Kittner SJ, Ay H, Brown RD, Meschia JF, Rundek T, Wassertheil-Smoller S, Woo D, Andsberg G, Biffi A, Brenner DA, Cole JW, Corriveau R, de Bakker PIW, Delav...> ;Neurology. 2014-10-28
• Fine mapping for Weaver syndrome in Brown Swiss cattle and the identification of 41 concordant mutations across NRCAM, PNPLA8 and CTTNBP2.
  McClure M, Kim E, Bickhart D, Null D, Cooper T, Cole J, Wiggans G, Ajmone-Marsan P, Colli L, Santus E, Liu GE, Schroeder S, Matukumalli L, Van Tassell C, Sonstegard T> ;PLoS ONE. 2013-01-01
• 26 citations
  Cancer stem cell and stromal microenvironment.
  Li Li, John T. Cole, David A. Margolin> ;Ochsner Journal. 2013 Jan 1
• Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.
  Hollak CEM, Belmatoug N, Cole JA, Vom Dahl S, Deegan PB, Goldblatt J, Rosenbloom B, van Dussen L, Tylki-Szymańska A, Weinreb NJ, Zimran A, Cappellini MD> ;Br. J. Haematol.. 2012-08-01
• 41 citations
  A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential.
  Chung-Gi Lee, Bikul Das, Tara L. Lin, Chelsea Grimes, Xin Zhang, Tracey Lavezzi, Li Huang, John T. Cole, Lillian C. Yau, Li Li> ;British Journal of Haematology. 2012 Jul 1
• Characterization of HIV-Associated Hodgkin's Lymphoma in HIV-Infected Patients: A Single-Center Experience.
  Ruiz, M., Parsons, C., Cole, J.> ;J Int Assoc Physicians AIDS Care (Chic). 2012 Feb 04
• Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.
  Mistry PK, Weinreb NJ, Kaplan P, Cole JA, Gwosdow AR, Hangartner T> ;Blood Cells Mol. Dis.. 2011-01-15
• 77 citations
  Pegylated arginase I: a potential therapeutic approach in T-ALL
  Claudia Hernandez, Kevin Morrow, Lluis A. Lopez-Barcons, Jovanny Zabaleta, Rosa A. Sierra, Cruz Velasco, John T. Cole, Paulo C. Rodriguez> ;Blood. 2010 Jun 24
• Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
  Mistry PK, Deegan P, Vellodi A, Cole JA, Yeh M, Weinreb NJ> ;Br. J. Haematol.. 2009-11-01
• Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.
  Grabowski GA, Kacena K, Cole JA, Hollak CEM, Zhang L, Yee J, Mistry PK, Zimran A, Charrow J, vom Dahl S> ;Genet. Med.. 2009-02-01
• 2 citations
  Chicken sarcoma to human cancers: a lesson in molecular therapeutics.
  Om Prakash, Stephen F. Bardot, John T. Cole> ;Ochsner Journal. 2007 Jan 1
• 15 citations
  A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932
  Edith A. Perez, Vera J. Suman, Tom R. Fitch, James A. Mailliard, James N. Ingle, John T. Cole, Michael H. Veeder, Patrick J. Flynn, Daniel J. Walsh, Ferdinand Addo> ;Oncology. 2005 Sep 1
• A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyelo...
  Hesketh, P.J., Arena, F., Patel, D., Austin, M., D'Avirro, P., Rossi, G., Colowick, A., Schwartzberg, L., Bertoli, L.F., Cole, J.T., Demetri, G., Dessypris, E., Dobbs,...> ;Cancer. 2004 Feb 15
• 1 citations
  Recent advances in the systemic therapy of breast cancer.
  John T. Cole> ;Ochsner Journal. 2000 Jan 1
• Can breast cancer be prevented
  Carl G. Kardinal, John T. Cole> ;Ochsner Journal. 2000 Jan 1
• 7 citations
  Sepsis due to coryneform group A-4 in an immunocompromised host
  Greg A. Bizette, Sandra A. Kemmerly, John T. Cole, Henry B. Bradford, Barbara H. Peltier> ;Clinical Infectious Diseases. 1995 Nov 1
• Is breast preservation possible in women with large, locally advanced breast cancers?
  Kuske RR, Farr GH, Harris K, Bolton JS, Sardi A, McKinnon WH, Kardinal CG, Cole J, Pickett TK, Graham ML> ;J La State Med Soc. 1993-04-01
• 3 citations
  A phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer.
  Kapil N. Bhalla, M. Birkhofer, Meenakshi Bhalla, Jose Lutzky, Alex Hindenburg, John T. Cole, Carol Ince> ;American Journal of Clinical Oncology. 1991 Dec 1
• Join now to see all

Journal Articles

• A Phase 1 Study of a Combination of Allopurinol, 5-Fluourouracil and Leucovorin Followed by Hydroxyeurea in patients with Advanced Gastrointestinal and Breast Cancer.  
  Phase 1 Study of a Combination of Allopurinol, 5-Fluourouracil and Leucovorin Followed by Hydroxyeurea in patients with Advanced Gastrointestinal and Breast Cancer., American Journal of Clinical Oncology, 1991
• Effects in vitro of 2’deoxycytidine on the Metabolism and Cytotoxicity of 2’3’-dideoxycytidine.  
  7. Bhalla KN, Gongrong L, Grant S, Cole J, MacLaughlin WW, and Volsky DJ, Aids, 1990
• Reversal of continuously administered high dose ara-c mediated toxicity by deoxycytidine in cultured human leukemia and normal human myeloid progenitors.  
  1. Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S, Blood, 1985